Half of patients say convenience and access to care are the most important factors influencing their decision-making—and investors are looking to capitalize on this demand for convenience. Last year, venture capital investors poured $1.4 billion into on-demand health care services, including telemedicine companies (e.g., Doctor on Demand) and patient-centered drug delivery (e.g., Nurx and Hims).
They’re all making a similar bet: These disruptors can give patients better and easier access than existing channels. If health systems aren’t careful, they risk losing core patient groups to these new entrants. In fact, over 60% of patients under age 45 already opt for a PCP-alternative (e.g., urgent care) as a first stop for common medical issues.